The Effect of Inspiratory Muscle Warm-up on Decreased Diffusing Capacity for Carbon Monoxide After Maximal Exercise in Athletes

ConditionAthlete
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age18-24
SponsorEmre Karaduman

About this trial

This study aims to examine the effects of inspiratory muscle warm-up (IMW) on the gas exchange capacity of the lungs (DLCO) and its potential contribution to recovery and athletic performance in elite athletes from various disciplines. The study hypothesizes that the decline in respiratory muscle capacity following high-intensity exercise, which negatively affects ventilation, diffusion, and oxygen transport, may be ameliorated through specific IMW protocol. A placebo-controlled, randomized, crossover, and double-blind design will be utilized, involving 28 elite male athletes from endurance, power, skill-based, and mixed disciplines.

Participants will complete three warm-up protocols: General Warm-up (GW), General Warm-up combined with IMW at 40% resistance intensity (GW+IMW40%), and a placebo condition (GW+IMWplacebo). Measurements will include respiratory muscle strength, DLCO (assessed at post-2, 30, 60, 90, and 120 minutes), respiratory function, and cardiorespiratory parameters during maximal exercise. This study is unique as it aims to detail the micro-level effects of IMW on pulmonary diffusion mechanisms and performance outcomes, providing novel insights into the ameliorative effects of IMW on respiratory function post-exercise. Additionally, it seeks to expand understanding of the mechanistic basis of IMW's benefits on both pulmonary diffusion capacity and athletic performance.

Eligibility criteria

Qualifiers

Age between 18-24 years.

A training history of at least six years.

Regular training frequency of at least four sessions per week.

Disqualifiers

History of smoking.

History of physical disability or acute respiratory or cardiovascular disease within the past three months.

Diagnosis of SARS-CoV-2 within the past three months.

Pulmonary function measurements outside the normal clinical range (≤ 80%).

Trial design

Treatments tested in this trial

  • General warm-up
  • Inspiratory muscle warm-up (Placebo - %15)
  • Inspiratory muscle warm-up (%40 IMW)

Treatment groups

28 Participants
are divided into 3 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Emre Karaduman

Lead sponsor

Ondokuz Mayıs University

Sponsor institution